Status:
COMPLETED
Detection of Plasma DNA in Non Small Cell and Small Cell Lung Cancer Patients
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Non-Small Cell Lung Carcinoma
Small Cell Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The majority of lung cancer patients have a tumor-derived genetic alteration in circulating plasma DNA that could be exploited as a diagnostic tool. The aim of this study is to evaluate if plasma DNA ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Presence of lung tumor to use fiberoscopy or surgical intervention for diagnosis.
- No lung instability.
- Individuals give all informed consent
Exclusion
Key Trial Info
Start Date :
December 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2011
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00213798
Start Date
December 1 2003
End Date
August 1 2011
Last Update
December 22 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Pneumologie, Hôpital Lyautey
Strasbourg, France, 67000
2
Service de Chirurgie Thoracique, Hôpital Civil
Strasbourg, France, 67091
3
Service de Pneumologie, Hôpital Civil
Strasbourg, France, 67091
4
Service de Pneumologie, Hôpital de Hautepierre
Strasbourg, France, 67098